Skip to main content

Animations

MJFF Publications

3111 - 3120 of 9156 Results
Title
Year
  • Year
  • 2023
  • 2019
  • 2019
  • 2019
  • 2017
  • 2021
  • 2020
  • 2019
  • 2024
  • 2017
  • Summary Details
    OPEN
    Title: Linear ubiquitination induces NEMO phase separation to activate NF-κB signaling
    Journal Name: Life Science Alliance
    Publisher: Life Science Alliance, LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.26508/lsa.202201607
    Citation Count: 40
  • PDkit
    2019
    Summary Details
    RESTRICTED
    Title: PDkit
    Journal Name: Adjunct Proceedings of the 2019 ACM International Joint Conference on Pervasive and Ubiquitous Computing and Proceedings of the 2019 ACM International Symposium on Wearable Computers
    Publisher: ACM
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1145/3341162.3346277
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1172/jci.insight.126769
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Oligomeric α-Synuclein Is Increased in Basal Tears of Parkinson’S Patients
    Journal Name: Biomarkers in Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.2217/bmm-2019-0167
    Citation Count: 59
  • Summary Details
    OPEN
    Title: The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.01.012
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease models
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1172/jci.insight.148649
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa096
    Citation Count: 207
  • Summary Details
    OPEN
    Title: Levels of Oligomeric α-Synuclein in Reflex Tears Distinguish Parkinson'S Disease Patients From Healthy Controls
    Journal Name: Biomarkers in Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.2217/bmm-2019-0315
    Citation Count: 45
  • Summary Details
    RESTRICTED
    Title: Mapping the human brain proteome: opportunities, challenges, and clinical potential
    Journal Name: Expert Review of Proteomics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1080/14789450.2024.2313073
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Drug repurposing to target proteostasis and prevent neurodegeneration: accelerating translational efforts
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awx107
    Citation Count: 20
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.